0001209191-22-021455.txt : 20220329 0001209191-22-021455.hdr.sgml : 20220329 20220329161255 ACCESSION NUMBER: 0001209191-22-021455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220328 FILED AS OF DATE: 20220329 DATE AS OF CHANGE: 20220329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thedinga Angela CENTRAL INDEX KEY: 0001804588 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 22780915 MAIL ADDRESS: STREET 1: C/O ADVERUM BIOTECHNOLOGIES, INC. STREET 2: 1035 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-582-4923 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-28 0 0001787400 Nkarta, Inc. NKTX 0001804588 Thedinga Angela C/O NKARTA, INC. 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 11.15 2022-03-28 4 A 0 32000 0.00 A 2032-03-27 Common Stock 32000 32000 D This option is scheduled to vest and become exercisable in three substantially equal installments on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer. /s/ Alicia Hager, as Attorney-in-Fact 2022-03-29